58
GeNeuro SA – 2023 Universal Registration Document
Kremer D, Schichel T, Förster M, Tzekova N, Bernard C, van der Valk P, van Horssen J, Hartung HP, Perron H,
Küry P. "Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell
differentiation". Ann Neurol. 2013 Nov; 74(5):721-32.
Kremer D, Förster M, Schichel T, Göttle P, Hartung HP, Perron H, Küry P. "The neutralizing antibody temelimab
abrogates W-ENVelope protein-mediated oligodendroglial maturation blockade". Mult Scler. 2015 Aug; 21(9):1200-
03.
Kremer D, Gruchot J, Weyers V, Oldemeier L, Göttle P, Hartung H-P, Küry P." W-ENVelope protein fuels microglial
cell dependent damage of myelinated axons in multiple sclerosis", Proc Natl Acad Sci U S A. 2019 May
Küry P, Nath A, Créange A, Dolei A, Marche P, Gold J, Giovannoni G, Hartung HP, Perron H. Human Endogenous
Retroviruses in neurological diseases. Trends In Molecular Medicine 2018: DOI information:
10.1016/j.molmed.2018.02.007
Levet S, Medina J, Joanou J, Demolder A, Queruel N, Réant K, Normand M, Seffals M, Dimier J, Germi R, Piofczyk
T, Portoukalian J, Touraine JL, Perron H. "An ancestral retroviral protein identified as a therapeutic target in type-1
diabetes. " JCI Insight. 2017 Sep 7;2(17). pii: 94387.
Madeira A, Burgelin I, Perron H, Curtin F, Lang AB, Faucard R. MSRV envelope protein is a potent, endogenous
and pathogenic agonist of human toll-like receptor 4: Relevance of temelimab in multiple sclerosis treatment. J
Neuroimmunol. 2016 Feb. 15;291:29-38.
Mameli, G., et al., "Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress
MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6." J Gen Virol, 2007. 88(Pt
1): 264-74.
Medina J, Perron H. DNA sequences from mobile genetic elements, a hidden half of the human genome. Med Sci
(Paris). 2017 Feb;33(2):151-158.
Medina, J., et al., Endogenous retroviral sequences in the human genome can play a physiological or pathological
role. Med Sci (Paris), 2017. 33(4): p. 397-403.
Morandi, E., et al., The association between human endogenous retroviruses and multiple sclerosis: A systematic
review and meta-analysis. PLoS One, 2017. 12(2): p. e0172415.
Perron H, Lalande B, Gratacap B, Laurent A, Genoulaz O, Geny C, Mallaret M, Schuller E, Stoebner P, Seigneurin
JM. Isolation of retrovirus from patients with multiple sclerosis. Lancet. 1991 Apr 6;337(8745):862-3.
Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset
C, Blond JL, Lalande B, Seigneurin JM, Mandrand B. Molecular identification of a novel retrovirus repeatedly
isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl
Acad Sci U S A. 1997 Jul 8;94(14):7583-8.
Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO,
Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R,
Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J,
Pelletier J, Hartung HP (2012). "Human endogenous retrovirus type W envelope expression in blood and brain cells
provides new insights into multiple sclerosis disease". Mult Scler. 2012 Dec;18(12):1721-36.
Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F,
Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M. Multiple sclerosis
retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal
Vbeta16 T-lymphocyte activation. Virology. 2001 Sep 1;287(2):321-32
Perron, H., et al., "Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic
patients."Biol Psychiatry, 2008. 64(12): 1019-23.
Perron, H., et al., "Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar
disorder". Transl Psychiatry, 2012. 2: p. e201.
Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN (2006), "The envelope protein of a human
endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses".
J Immunol 176:7636-44.
Ruprecht, K., et al., "Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous
retrovirus W in patients with multiple sclerosis." J Neurovirol, 2008. 14(2):143-51.
Saresella, M., et al., "Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in
patients with relapsing-remitting multiple sclerosis". Mult Scler, 2009. 15(4): p. 443-7.
van Horssen J, van der Pol S, Nijland P, Amor S, Perron H. Human endogenous retrovirus W in brain lesions:
Rationale for targeted therapy in multiple sclerosis. Mult Scler Relat Disord. 2016 Jul;8:11-8.
Zimmermann M, Sanderson NS, Rasenack M, Lalive PH, Lang AB, Curtin F, Lindberg RL, Kappos L, Derfuss T.
Immunologic monitoring during a Phase IIa trial of the temelimab antibody in patients with MS. Neurol
Neuroimmunol Neuroinflamm. 2015 Aug20;2(5):e144.